What we have discovered
New sources of plant extracts that have shown high antioxidant or anti-proliferative activity in various preclinical trials, both in vitro and in vivo.
At the moment CELLBITEC has patented so many plant extracts with a proven biofunctional capacity, as well as its extraction methodology and the isolation of several of these molecules by means of nanotechnology.
Cellbitec has several research projects funded through programmes of the European Union, the Ministry of Science, Innovation, Universities of the Spanish Government and the Carlos III Institute of Health together with the Centre for Technological Development and Innovation of Spain, where it continues to focus on the screening of new molecules in different plant genera and species, as well as the development of new drugs with the molecules already identified.
PHASES IN THE STUDY OF A MEDICINAL PRODUCT
DISCOVERY
PATENT
STRUCTURAL CLARIFICATION
ISOLATION
PURIFICATION
TAXONOMY
PRECLINICAL
TOXICITY
PHARMACOKINETICS
FORMULATION
STABILITY
BIOLOGICAL STUDIES
PHASE I
DOSIFICATION
ADMINISTRATION
TOXICITY
PHARMACOKINETICS
SECURITY
PHASE II
EFICIENCY
SECURITY
THERAPEUTIC INDICATION
PHASE III
COMPARISON WITH STANDARD TREATMENTS
REGISTRATION: REVIEW AND APPROVAL BY HEALTH AUTHORITIES (FDA/EMEA)
2 AND 4 YEARS
3 TO 7 YEARS